Plasma Therapy Market Size, Share & Trends Analysis Report Forecast Period 2024-2031.

The global plasma therapy market is anticipated to grow at a significant CAGR of 13.1% during the forecast period. The factors driving the plasma therapy market are the rising prevalence of life-threatening diseases which includes various neurological system disorders such as chronic inflammatory demyelinating polyneuropathy (CIPD), idiopathic thrombocytopenic purpura (ITP), multifocal motor neuropathy (MMN). In addition, the rise in the occurrence of contagious diseases such as hepatitis A&B, tetanus, and rabies is estimated to impact the market positively during the forecast period.

Get Sample Copy of this Report at

https://www.omrglobal.com/request-sample/plasma-therapy-market

An impressive technological advancement over the period has added much more to the therapies for the treatment of various diseases which has also led to the introduction of cost-effective protein fractioning technologies from plasma. This is also being seen as a major booster to the growth of the plasma therapy market during the forecast period. As per estimates by the World Health Organization (WHO) about 108 million global blood donations come from high-income countries, which is the home to 18% of the world's population. The presence of a favorable government initiates the development of plasma-derived medicine and raising awareness regarding the importance of blood donation are the key drivers for this market.

Segmental Outlook

The global plasma therapy market is segmented based on type, application, and end-user. Based on type, the plasma therapy market is segmented into leukocyte-rich fibrin (L-PRF), pure platelet-rich fibrin (PRF), leucocyte-rich PRP, and pure PRP. The pure PRP segment is estimated to account for the largest share of the global market during the forecast period. One of the most significant factors driving the growth of this market includes the effective results of pure PRP therapy. However, the lack of reimbursement policies and varying prices of plasma therapy are hindering the growth of the market. Based on application, the plasma therapy market is segmented into orthopedics, dermatology, dental, and others. The orthopedic segment is further segmented into arthritis, chronic tendinitis, and bone repair & regeneration. Similarly, the dermatology segment is further segmented into androgenic alopecia and plastic surgery. Based on end-user, the market is classified into hospitals & clinics, and research institutions. The hospitals & clinics segment is estimated to account for the largest share of the global market during the forecast period.

The orthopedics segment is anticipated to hold a significant share in the market owing to the increase in the incidence rate of orthopedic diseases. According to the World Health Organization (WHO), symptomatic osteoarthritis affects 9.6% of men and 18% of women over the age of 60 worldwide. 80% of them have movement restrictions, and 25% are unable to do daily tasks.

Regional Outlooks

The global plasma therapy market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. The North American region is anticipated to be the fastest-growing region in the plasma therapy market owing to the growing number of hospitals and clinics which is increasing the demand for plasma therapy. The key driving forces expected to boost the market of plasma therapy in North America are rising awareness levels among blood donors, the presence of advanced protein fractioning procedures, and higher per capita income in developed countries.

The North American Region is Anticipated to hold the Prominent Share in the Global Plasma Therapy Market

The North American region is anticipated to hold a prominent share of the plasma therapy market owing to the rise in the prevalence of numerous diseases, such as arthritis, well-established healthcare infrastructure, improved regulatory environment, and government assistance. According to a poll done by the Centers for Disease Control and Prevention (CDC) in 2020, one out of every four persons in the US had arthritis, with a projected 78 million adults anticipated to suffer from the disease by 2040. Furthermore, the prevalence of doctor-diagnosed arthritis is predicted to climb dramatically in the region during the forecast period, owing to the region's aging population. Osteoarthritis is the most common kind of arthritis, affecting around 31 million Americans each year.

by Type (Leukocyte-Rich Fibrin (L-PRF), Pure Platelet-Rich Fibrin (PRF), Leucocyte-Rich PRP, and Pure PRP),

by Application (Orthopedics, Dermatology, Dental, and Others), and

by End-User (Hospitals & Clinics and Research Institutions)

Market Players Outlook

The major companies serving the global plasma therapy market include Arthrex Inc., China Biologic Products Inc., and Johnson and Johnson. The companies are focusing on product innovations, expansions, mergers and acquisitions, and finding a new market or innovation in their core competency to expand individual market share. For instance, PRP (Platelet-rich Plasma) Microneedling Facelifts for patients were introduced by Atlas Health Medical Group in February 2021.

The Report Covers

Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global plasma therapy market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Inquire for Discount on this Report at

https://www.omrglobal.com/report-customization/plasma-therapy-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.